Nadtha Panin

938 total citations
24 papers, 728 citations indexed

About

Nadtha Panin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Nadtha Panin has authored 24 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in Nadtha Panin's work include Drug Transport and Resistance Mechanisms (7 papers), Cystic Fibrosis Research Advances (5 papers) and HIV/AIDS drug development and treatment (5 papers). Nadtha Panin is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cystic Fibrosis Research Advances (5 papers) and HIV/AIDS drug development and treatment (5 papers). Nadtha Panin collaborates with scholars based in Belgium, Netherlands and Italy. Nadtha Panin's co-authors include Dominique Lison, François Huaux, Virginie Rabolli, Julie Muller, Laure Elens, Vincent Haufroid, Monique Delos, Pierre Wallemacq, Jean‐Baptiste Demoulin and Martine De Meyer and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Nadtha Panin

22 papers receiving 720 citations

Peers

Nadtha Panin

PRM

ONCOL

PPCH

HTM

Mohammed Abbas Virji United States

Chengcheng Li China

Man C. Fung United States

James D. Henderson United States

Liu Huang China

Mathias Haarhaus Sweden

Huili Dai China

Xiaoyu Shi China

J Fleury France

Yali Liu China

Mohammed Abbas Virji United States

Nadtha Panin

36 ×0.2

41 ×0.3

PRM

46 ×0.3

ONCOL

80 ×0.7

PPCH

35 ×0.3

HTM

Citations per year, relative to Nadtha Panin Nadtha Panin (= 1×) peers Mohammed Abbas Virji

Countries citing papers authored by Nadtha Panin

Since Specialization

Citations

This map shows the geographic impact of Nadtha Panin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadtha Panin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadtha Panin more than expected).

Fields of papers citing papers by Nadtha Panin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadtha Panin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadtha Panin. The network helps show where Nadtha Panin may publish in the future.

Co-authorship network of co-authors of Nadtha Panin

This figure shows the co-authorship network connecting the top 25 collaborators of Nadtha Panin. A scholar is included among the top collaborators of Nadtha Panin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadtha Panin. Nadtha Panin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greef, Julien De, Jean Cyr Yombi, Anne Vincent, et al.. (2025). Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study. The Journal of Infectious Diseases. 231(6). 1425–1429. 1 indexed citations

Deldicque, Louise, Giulio G. Muccioli, Nadtha Panin, et al.. (2025). Silencing drug transporters in human primary muscle cells modulates atorvastatin pharmacokinetics: A pilot study. British Journal of Pharmacology. 182(9). 2049–2066.

Greef, Julien De, et al.. (2024). Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell lines. Scientific Reports. 14(1). 16290–16290. 1 indexed citations

Paquot, Adrien, et al.. (2022). Genetic Polymorphisms in SLCO2B1 and ABCC1 Conjointly Modulate Atorvastatin Intracellular Accumulation in HEK293 Recombinant Cell Lines. Therapeutic Drug Monitoring. 45(3). 400–408. 4 indexed citations

Panin, Nadtha, et al.. (2021). Effect of four ABCB1 genetic polymorphisms on the accumulation of darunavir in HEK293 recombinant cell lines. Scientific Reports. 11(1). 9000–9000. 3 indexed citations

Bouzin, Caroline, Emmanuel Hermans, M. Delion, et al.. (2020). Vardenafil increases intracellular accumulation of the most prevalent mutant CFTR in human bronchial epithelial cells. Biology Open. 9(8). 1 indexed citations

Panin, Nadtha, et al.. (2018). Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines. Scientific Reports. 8(1). 10514–10514. 14 indexed citations

Noël, Sabrina, et al.. (2017). Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms. Clinical Science. 131(11). 1107–1121. 12 indexed citations

Belkhir, Leïla, Laure Elens, Francis Zech, et al.. (2016). Interaction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 Polymorphism. PLoS ONE. 11(10). e0165631–e0165631. 10 indexed citations

10.

Panin, Nadtha, et al.. (2016). Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib. Scientific Reports. 6(1). 29559–29559. 31 indexed citations

11.

Leal, Teresinha, François Huaux, Nadtha Panin, et al.. (2016). Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium. Frontiers in Immunology. 7. 499–499. 8 indexed citations

12.

Huaux, François, Francine Uwambayinema, Saloua Ibouraadaten, et al.. (2015). Mesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cells. Particle and Fibre Toxicology. 13(1). 46–46. 36 indexed citations

13.

Elens, Laure, Nadtha Panin, Arnaud Capron, et al.. (2014). ABCB1 1199G>A Genetic Polymorphism (Rs2229109) Influences the Intracellular Accumulation of Tacrolimus in HEK293 and K562 Recombinant Cell Lines. PLoS ONE. 9(3). e91555–e91555. 39 indexed citations

14.

Huaux, François, Sandra Lo Re, Francine Uwambayinema, et al.. (2014). IL‐1α induces CD11b^low alveolar macrophage proliferation and maturation during granuloma formation. The Journal of Pathology. 235(5). 698–709. 33 indexed citations

15.

Huaux, François, Sabrina Noël, Nadtha Panin, et al.. (2013). Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis. PLoS ONE. 8(5). e64341–e64341. 30 indexed citations

16.

Lubamba, Bob, François Huaux, Jean Lebacq, et al.. (2012). Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice. Journal of Cystic Fibrosis. 11(4). 266–273. 23 indexed citations

17.

Muller, Julie, Monique Delos, Nadtha Panin, et al.. (2012). Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicological Sciences. 128(2). 553–553.

18.

Elens, Laure, Donatienne Tyteca, Nadtha Panin, et al.. (2011). Functional defect caused by the 4544G>A SNP in ABCC2. Pharmacogenetics and Genomics. 21(12). 884–893. 29 indexed citations

19.

Elens, Laure, Ron HN van Schaik, Nadtha Panin, et al.. (2011). Effect of a New FunctionalCYP3A4Polymorphism on Calcineurin Inhibitors‘ Dose Requirements and Trough Blood Levels in Stable Renal Transplant Patients. Pharmacogenomics. 12(10). 1383–1396. 124 indexed citations

20.

Muller, Julie, Monique Delos, Nadtha Panin, et al.. (2009). Absence of Carcinogenic Response to Multiwall Carbon Nanotubes in a 2-Year Bioassay in the Peritoneal Cavity of the Rat. Toxicological Sciences. 110(2). 442–448. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact